NIH funds study to evaluate remdesivir for COVID-19 in pregnancy
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who
Category: Uncategorized
Happy 70th Birthday, Lajos!
CycloLab celebrates birthday of L. Szente (70), former CEO Lajos Szente has been contributing to the development of the global
Changes in the management of CycloLab
Cyclolab, a company with unparalleled expertise in the manufacturing, design and formulation of cyclodextrins, announced the appointment of Tamas Sohajda
Use of sulfobutylether beta cyclodextrin for preparing ceramics
A very few patent applications may trace back prior art disclosure to the Neolithic Age (from 10000 – 4500 BC)
500th post in Cyclodextrin News blog
1986, the year of the first issue of Cyclodextrin News was abundant in notable events and new threats to be
FIRST EXPERIMENTS IN SPACE FOR COVID-19 DRUG RESEARCH
The COVID-19 pandemic has generated new and urgent challenges in drug discovery and development. Veklury®, a remdesivir-based medicament invented by
New cyclodextrin with orphan drug designation: SBECD
ReVision Therapeutics, Inc., a privately-held, early stage biopharmaceutical company focused on the development and commercialization of innovative therapies for ocular
UK grants early access for Gilead’s remdesivir in Covid-19
The government of the U.K. is granting the country’s equivalent to an emergency use authorization to remdesivir, the antiviral drug
First copies of Gilead’s SBECD-enabled remdesivir to start selling in Bangladesh
According to Hindustan Times, Bangladesh’s Beximco Pharmaceuticals Ltd. has become the world’s first company to start selling the generic version
Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19
Japan approved the Gilead Sciences antiviral drug remdesivir Thursday for treatment of severe COVID-19 patients, under an exceptional approval pathway